1. Home
  2. PZZA vs VALN Comparison

PZZA vs VALN Comparison

Compare PZZA & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Papa John's International Inc.

PZZA

Papa John's International Inc.

HOLD

Current Price

$33.82

Market Cap

1.0B

ML Signal

HOLD

Logo Valneva SE

VALN

Valneva SE

HOLD

Current Price

$10.32

Market Cap

875.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PZZA
VALN
Founded
1984
2012
Country
United States
France
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
875.7M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
PZZA
VALN
Price
$33.82
$10.32
Analyst Decision
Buy
Strong Buy
Analyst Count
8
4
Target Price
$45.00
$15.75
AVG Volume (30 Days)
1.7M
17.4K
Earning Date
05-07-2026
03-18-2026
Dividend Yield
5.36%
N/A
EPS Growth
N/A
N/A
EPS
0.90
N/A
Revenue
$2,068,421,000.00
N/A
Revenue This Year
N/A
$4.00
Revenue Next Year
N/A
$92.04
P/E Ratio
$38.17
N/A
Revenue Growth
14.07
N/A
52 Week Low
$30.16
$5.43
52 Week High
$55.74
$12.25

Technical Indicators

Market Signals
Indicator
PZZA
VALN
Relative Strength Index (RSI) 48.80 47.04
Support Level $33.30 $9.85
Resistance Level $34.89 $10.46
Average True Range (ATR) 1.97 0.42
MACD 0.32 -0.08
Stochastic Oscillator 37.26 18.08

Price Performance

Historical Comparison
PZZA
VALN

About PZZA Papa John's International Inc.

Papa John's is one of the largest players in the global QSR, or quick-service restaurant, pizza market, boasting more than 6,000 restaurants across nearly 50 countries at the end of 2024. The firm operates a predominantly franchised system, owning 9% of its restaurants and generating revenue from franchise royalties, sales of pizza and related products at its company-owned stores, and sales from its commissary supply chain. The firm is the fourth-largest limited-service pizza chain globally and third in the US (Euromonitor International), with a sizable presence in the UK, China, South Korea, and Chile.

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Share on Social Networks: